Tenon Medical (Tenon Medical) Change In Receivables : $-0.27 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Tenon Medical Change In Receivables?

Tenon Medical's change in receivables for the quarter that ended in Mar. 2024 was $-0.06 Mil. It means Tenon Medical's Accounts Receivable increased by $0.06 Mil from Dec. 2023 to Mar. 2024 .

Tenon Medical's change in receivables for the fiscal year that ended in Dec. 2023 was $-0.29 Mil. It means Tenon Medical's Accounts Receivable increased by $0.29 Mil from Dec. 2022 to Dec. 2023 .

Tenon Medical's Accounts Receivable for the quarter that ended in Mar. 2024 was $0.57 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Tenon Medical's Days Sales Outstanding for the three months ended in Mar. 2024 was 72.47.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Tenon Medical's liquidation value for the three months ended in Mar. 2024 was $0.74 Mil.

Tenon Medical Change In Receivables Historical Data

The historical data trend for Tenon Medical's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenon Medical Change In Receivables Chart

Tenon Medical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Receivables

0.04

-0.06

-0.15

-0.29

Tenon Medical Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial									-0.09	-0.29	-0.17	0.26	-0.06

Tenon Medical Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.27 Mil.

Tenon Medical (NAS:TNON) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Tenon Medical's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.571	/	0.719	*	91
=	72.47

2. In Ben Graham's calculation of liquidation value, Tenon Medical's accounts receivable are only considered to be worth 75% of book value:

Tenon Medical's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	4.388	-	4.396	+	0.75 * 0.571	+	0.5 * 0.632
=	0.74

Tenon Medical Change In Receivables Related Terms

Thank you for viewing the detailed overview of Tenon Medical's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Tenon Medical (Tenon Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tenon Medical Inc (NAS:TNON) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

104 Cooper Court, Los Gatos, CA, USA, 95032

Website

https://www.tenonmed.com

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Executives

Van Dick Steven M	officer: Chief Financial Officer	HANSEN MEDICAL, INC., 380 N BERNARDO AVENUE, MOUNTAIN VIEW CA 94043
Richard Ginn	director, officer: Chief Technology Officer	104 COOPER COURT, LOS GATOS CA 95032
Steven M Foster	director, officer: CEO and President	104 COOPER COURT, LOS GATOS CA 95032
Stephen Hochschuler	director	C/O TENON MEDICAL, INC., 104 COOPER COURT, LOS GATOS CA 95032
Frank M Fischer	director	9701 JERONIMO, IRVINE CA 92618
Richard M Ferrari	director	2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Ivan Howard	director	104 COOPER COURT, LOS GATOS CA 95032
Robert K Weigle	director	104 COOPER COURT, LOS GATOS CA 95032
Ventures Ag Zuhlke	10 percent owner	ZURCHERSTRASSE 39J, SCHLIEREN V8 8952